Package 55111-340-30

{"route": ["ORAL"], "spl_id": "6fafdf6a-6153-9a62-1774-755f2bcf0cc2", "openfda": {"upc": ["0355111339014", "0355111340010"], "unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898350", "898353", "898356"], "spl_set_id": ["ca014f06-982c-6fe1-9948-a3701dd35d34"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (55111-340-01)", "package_ndc": "55111-340-01", "marketing_start_date": "20100419"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (55111-340-05)", "package_ndc": "55111-340-05", "marketing_start_date": "20100419"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (55111-340-30)", "package_ndc": "55111-340-30", "marketing_start_date": "20100419"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "55111-340_6fafdf6a-6153-9a62-1774-755f2bcf0cc2", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "55111-340", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "Dr.Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA077183", "marketing_category": "ANDA", "marketing_start_date": "20100419", "listing_expiration_date": "20261231"}